The store will not work correctly when cookies are disabled.
2-(6-carbamoyl-7-methoxyquinolin-4-ylthio)acetic acid
ID: ALA3527507
PubChem CID: 118753335
Max Phase: Preclinical
Molecular Formula: C13H12N2O4S
Molecular Weight: 292.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2nccc(SCC(=O)O)c2cc1C(N)=O
Standard InChI: InChI=1S/C13H12N2O4S/c1-19-10-5-9-7(4-8(10)13(14)18)11(2-3-15-9)20-6-12(16)17/h2-5H,6H2,1H3,(H2,14,18)(H,16,17)
Standard InChI Key: KLHQDCXUCIKEGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
3.5982 -1.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5964 -2.4818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3117 -2.8943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3090 -1.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8832 -1.2428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1685 -1.6550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8811 -2.8929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1709 -2.4801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8801 -3.7166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0253 -1.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0222 -2.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7384 -2.8893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4499 -2.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4468 -1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7339 -1.2387 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7409 -3.7131 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.4529 -4.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1664 -3.7086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8826 -4.1183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1638 -2.8848 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 11 2 0
10 4 2 0
4 1 1 0
1 5 1 0
5 6 1 0
2 7 1 0
7 8 1 0
7 9 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
12 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.32 | Molecular Weight (Monoisotopic): 292.0518 | AlogP: 1.52 | #Rotatable Bonds: 5 |
Polar Surface Area: 102.51 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.24 | CX Basic pKa: 4.65 | CX LogP: -0.59 | CX LogD: -2.74 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.81 | Np Likeness Score: -0.93 |
References
1. Inoue K, Asai N, Mizuo H, Fukuda K, Kusano K, Yoshimura T.. (2012) Unique metabolic pathway of [(14)C]lenvatinib after oral administration to male cynomolgus monkey., 40 (4): [PMID:22207053] [10.1124/dmd.111.043281] |